Alveolus Bio
Birmingham
About Alveolus Bio
Alveolus Bio: Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. Their clinical pipeline includes preclinical phase live biotherapeutics for Bronchopulmonary Dysplasia (BPD), Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), and Pulmonary Arterial Hypertension (PAH).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: alveolusbio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/alveolus-bio-68570 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.